Dome Therapeutics Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Angel

  • Latest Deal Amount
  • $100K

  • Investors
  • 2

Dome Therapeutics General Information

Description

Operator of a biotechnology company intended to focus on developing groundbreaking nanomedicine-driven gene and cell therapies to treat neurological disorders. The company engages in applying biomaterials and nanomedicine technologies to program patient autologous stem cell-based treatments, enabling doctors to easily develop gene and cell therapies for revolutionizing the treatment of brain cancer and neurological disorders.

Contact Information

Website
www.dometherapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 123 Fifth Avenue
  • New York, NY 12004
  • United States
Primary Industry
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 123 Fifth Avenue
  • New York, NY 12004
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Dome Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Angel (individual) 26-Jan-2024 $100K Completed Startup
2. Accelerator/Incubator Completed Startup
1. Early Stage VC 24-Nov-2020 $150K $150K Completed Pre-Clinical Trials
To view Dome Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Dome Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Dome Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
The Eldov Group Venture Capital Minority
Johns Hopkins Technology Ventures Accelerator/Incubator Minority
To view Dome Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Dome Therapeutics FAQs

  • When was Dome Therapeutics founded?

    Dome Therapeutics was founded in 2019.

  • Where is Dome Therapeutics headquartered?

    Dome Therapeutics is headquartered in New York, NY.

  • What is the size of Dome Therapeutics?

    Dome Therapeutics has 3 total employees.

  • What industry is Dome Therapeutics in?

    Dome Therapeutics’s primary industry is Biotechnology.

  • Is Dome Therapeutics a private or public company?

    Dome Therapeutics is a Private company.

  • What is Dome Therapeutics’s current revenue?

    The current revenue for Dome Therapeutics is .

  • How much funding has Dome Therapeutics raised over time?

    Dome Therapeutics has raised $250K.

  • Who are Dome Therapeutics’s investors?

    The Eldov Group and Johns Hopkins Technology Ventures have invested in Dome Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process